DeutschNewstral
Article
jdsupra.com on 2017-12-21 00:55
Drug pricing in Canada: Changes for the PMPRB with proposed amendments to the Patented Medicines Regulations
Related news
- Canada releases proposed amendments to Regulations governing patented medicines pricingjdsupra.com
- PMPRB Update: Jurisdiction extends to CSPs effective June 30; coming into force of Patented Medicines Regulations and Guidelines delayed to January 2022jdsupra.com
- Update on amended Patented Medicines Regulationsjdsupra.com
- Slam dunk! New basket of countries for PMPRB reporting remain, controversial amendments to Patented Medicines Regulations droppedjdsupra.com
- PMPRB releases draft Guidelines operationalizing amended Patented Medicines Regulationsjdsupra.com
- Canada releases final amendments to Patented Medicines Pricing Regulations; in force July 1, 2020jdsupra.com
- PMPRB Updates: Definition of “Gap Medicine” amended, modified threshold for investigating the price of new patented medicinesjdsupra.com
- Amendments to PMPRB Regulations will now be in force January 1, 2021jdsupra.com
- PMPRB update: Revised compliance timelines for grandfathered and gap medicines and proposed regulatory amendments directed to CSPsjdsupra.com
- New PMPRB regulations registered, in force July 1, 2022, interim approach to pricing announcedjdsupra.com
- New amendments to PMPRB pricing regulations push back deadlines by six monthsjdsupra.com
- Federal Court strikes price calculation provision of amendments to Patented Medicines Regulationsjdsupra.com
- Innovators commence Court challenges regarding recent amendments to Patented Medicines Regulationsjdsupra.com
- Proposed amendments to the Patented Medicines (Notice of Compliance) Regulations would expand definition of “claim for the medicinal ingredient”jdsupra.com
- FCA remits pricing decision on ALEXION’S SOLIRIS to PMPRBjdsupra.com
- Revised draft Guidelines operationalizing the Patented Medicines Regulations: notable changesjdsupra.com
- Discussion Guide for PMPRB Phase 2 Consultations on New Guidelines outlines proposed new framework for patented medicine price reviewjdsupra.com
- Federal Court releases decision on validity of the Amending Regulations of the Patented Medicines Regulationsjdsupra.com
- PMPRB News: “significant changes” to be made to draft pricing Guidelinesjdsupra.com
- Countdown to July 1, 2020: Getting Ready for the New Patented Medicines Pricing Regimejdsupra.com